This is ctix's study. DF is running it for them but df don't own it. In an open label phI, the company has the right to information and may release as they see fit. It is obvious this company is choosing to adhere to a model resembling later stage study and wishes to preserve any results release until final cohort completion. If this was a phII or III study - your premise would be correct. This is an OPEN LABEL phI - you're premise is not correct.